https://profiles.bu.edu/Sophie.Claudel
www.statnews.com/wunderkinds/
www.statnews.com/wunderkinds/
#NephSky
#NephSky
CONFIDENCE trial of empagliflozin + finerenone in N = 579
Greater reduction in ACR and BP
Note the impressive GFR dip
www.nejm.org/doi/full/10....
CONFIDENCE trial of empagliflozin + finerenone in N = 579
Greater reduction in ACR and BP
Note the impressive GFR dip
www.nejm.org/doi/full/10....
#ASNJASN
@ashunephro.bsky.social
@sophieclaudel.bsky.social
@jaccjournals.bsky.social #NephSky
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social #NephSky
@nephjc.bsky.social #NephSky
“Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review"
www.ahajournals.org/eprint/SXXGK...
@ahascience.bsky.social
@ahajournals.bsky.social
@asnkidney.bsky.social
@nephjc.bsky.social #NephSky
authors.elsevier.com/a/1khiu2gOwG...
authors.elsevier.com/a/1khiu2gOwG...
academic.oup.com/jalm/advance...
Our new analysis @urbaninstitute.bsky.social shows this would disproportionately fund:
—Communities with a higher white resident share
—Low-density areas
—High-income areas
—Car-dependent areas
Our new analysis @urbaninstitute.bsky.social shows this would disproportionately fund:
—Communities with a higher white resident share
—Low-density areas
—High-income areas
—Car-dependent areas
#NephJC chat 2/11/25 at 9pm EST #NephSky
www.nephjc.com/news/primary...
link.springer.com/article/10.1...
link.springer.com/article/10.1...